摘要
目的:探讨阿奇霉素序贯疗法联合孟鲁司特钠治疗小儿支原体肺炎的临床分析。方法:选取2018年11月至2020年6月的医院临床治疗的患有小儿支原体肺炎的患者50例作为研究对象,随机分成观察组(n=25例)和对照组(n=25例),对照组采用单纯阿奇霉素进行治疗,观察组采用阿奇霉素序贯疗法联合孟鲁司特钠进行治疗;治疗后,对患者的治疗效果进行有效评估,比较两组患者的临床相关指标变化以及治疗后的总有效率。结果:治疗后,观察组患者肺部啰音消失时间、咳嗽消失时间,住院时间以及退热时间均低于对照组(P<0.05),治疗后,观察组患者的总有效率高于对照组(P<0.05)。结论:临床上使用阿奇霉素序贯疗法联合孟鲁司特钠治疗小儿支原体肺炎,能够有效缓解患者的肺部啰音以及咳嗽症状,降低退热时间以及住院时间,提高患者生活质量,能够有效提高患者临床治疗效果,有利于患者恢复。
Objective:To explore the clinical analysis of Azithromycin Sequential Therapy Combined with montelukast sodium in the treatment of mycoplasma pneumonia in children.Methods:from November 2018 to June 2020,50 patients with mycoplasma pneumonia in children were randomly divided into observation group(n=25)and control group(n=25).The control group was treated with azithromycin alone,and the observation group was treated with Azithromycin Sequential Therapy Combined with montelukast sodium;After treatment,the treatment effect of patients was effectively evaluated,and the changes of clinical related indicators and the total effective rate of the two groups were compared.Results:after treatment,the disappearance time of pulmonary rales,cough,hospitalization time and antipyretic time of the observation group were lower than those of the control group(P<0.05),and the total effective rate of the observation group was higher than that of the control group(P<0.05).Conclusion:the clinical use of Azithromycin Sequential Therapy Combined with montelukast sodium in the treatment of children with mycoplasma pneumonia can effectively alleviate the lung rales and cough symptoms of patients,reduce the fever time and hospitalization time,improve the quality of life of patients,can effectively improve the clinical treatment effect of patients,and is conducive to the recovery of patients.
作者
李军
LI Jun(Department of Pediatrics,Dongtai people's Hospital,Dongtai Jiangsu 224200,China)
出处
《医学食疗与健康》
2021年第9期69-70,共2页
Medical Diet and Health
关键词
阿奇霉素序贯疗法
孟鲁司特钠
小儿支原体肺炎
Azithromycin Sequential Therapy
Montelukast sodium
Mycoplasma pneumonia in children
